Congress Wealth Management LLC DE Has $11.54 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Congress Wealth Management LLC DE increased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,715 shares of the company’s stock after purchasing an additional 8,505 shares during the period. Congress Wealth Management LLC DE’s holdings in Prestige Consumer Healthcare were worth $11,535,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth about $42,593,000. Boston Trust Walden Corp lifted its holdings in Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock worth $64,942,000 after purchasing an additional 252,089 shares during the last quarter. Natixis Advisors LLC boosted its position in Prestige Consumer Healthcare by 1,335.1% during the fourth quarter. Natixis Advisors LLC now owns 209,246 shares of the company’s stock worth $16,340,000 after purchasing an additional 194,665 shares during the period. Wellington Management Group LLP acquired a new position in Prestige Consumer Healthcare during the third quarter valued at approximately $6,342,000. Finally, Great Lakes Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 113.7% in the fourth quarter. Great Lakes Advisors LLC now owns 139,116 shares of the company’s stock valued at $10,864,000 after purchasing an additional 74,016 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PBH. Royal Bank of Canada raised their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research note on Friday. Canaccord Genuity Group raised their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research report on Monday, December 9th. DA Davidson lifted their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Finally, StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $85.46 on Tuesday. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $90.04. The company has a market capitalization of $4.23 billion, a P/E ratio of 20.01, a P/E/G ratio of 2.69 and a beta of 0.46. The stock has a 50 day moving average of $82.67 and a two-hundred day moving average of $78.72. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.